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Abstract
We report a case of Wegener's Granulomatosis (WG) associated with blastomycosis. This appears
to be the first case report of WG co-existing with a tissue proven blastomycosis infection. The
temporal correlation of the two conditions suggests that blastomycosis infection (and therefore
possibly other fungal infections), may trigger the systemic granulomatous vasculitis in a predisposed
individual; a provocative supposition warranting further study.
Introduction
Wegener's Granulomatosis is a systemic small vessel vas-
culitis of unknown etiology, associated with the presence
of anti-neutrophil cytoplasmic antibodies ANCA usually
C-ANCA directed against Proteinase 3 (PR-3). It is postu-
lated that auto-immune and infectious mechanisms play
a role in the pathogenesis [1]. Viral, bacterial and fungal
infections have been reported in association with ANCA
positive vasculitis. The presence of infection suggests that
pathogens may act as potential triggers of an inflamma-
tory cascade ultimately resulting in vascular inflammation
[2]. We report a case of WG that may have been triggered
by blastomycosis. To our knowledge, this is the first
reported case of such an association.
Case presentation
A 16 year old previously healthy girl presented with a 3
day history of progressive pain and swelling in the right
calf with inability to bear weight. On further questioning,
she also complained of arthralgias, myalgias for the past
month with history of intermittent chest pain in the
absence of cough or dyspnea for the previous 3 months.
In addition, she had generalized constitutional symptoms
of generalized fatigue and malaise for the past 2 weeks.
She had no history of fever, night sweats weight loss, rash,
ocular, ear, nose, throat, gastrointestinal or genitourinary.
These symptoms occurred 3 months following a 2 week
travel to Kenora, Ontario. Physical examination was unre-
markable, with the exception of a swollen warm and
exquisitely tender right calf.
A Computerized Tomography (CT) scan of the chest and
an ultrasound Doppler of right leg were performed
because of concern of deep vein thrombosis (DVT) and
pulmonary embolism. Chest CT showed a 3 cm cavitary
lesion in the left upper lobe with surrounding consolida-
tion (figure 1). Ultrasound Doppler showed no evidence
of DVT. Acute phase reactants were elevated: ESR 56 mm/
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hr and C reactive protein 60 mg/l. Urinalysis showed trace
protein and 9 RBC/HPF with no urinary sedimentation or
casts. Other initial investigations including a complete
blood count, liver enzymes and creatinine kinase were
normal. The initial working diagnosis was a pulmonary
infection with a septic embolus in the calf musculature.
The patient was treated with broad spectrum antibiotics
with rapid resolution of the calf pain and swelling.
However, although she improved, she continued to have
migrating polymyalgias, arthralgias and intermittent trace
hematuria prompting investigations for an underlying
rheumatic disease. Antinuclear antibodies including anti-
double stranded DNA, and anti-extractable nuclear anti-
gens were all negative. However, C-ANCA was positive by
immunoflurescence and PR3 titer by ELSIA was strongly
positive at 94 (positive levels > 30). suggestive of a diag-
nosis of WG. Because there was a recent travel history to
Kenora, Ontario, a region with a high incidence of blasto-
mycosis, a bronchoscopy and an open lung biopsy were
preformed. The lung biopsy revealed fungal yeast forms
compatible with blastomycosis, and changes of necrotiz-
ing granulomatous inflammation and vasculitis compati-
ble with WG. The extent of the necrotizing granulomatous
disease and the necrotizing vasculitis, seemed more than
would be expected with blastomycosis alone.
Because of the concern that immunosuppressive therapy
might lead to disseminated blastomycosis, and as there
remained some question that blastomycosis alone could
explain all her symptoms and laboratory findings it was
elected to initially treat her with the anti-fungal agent Itra-
conazole alone. With this treatment there was some
improvement in chest pain and the radiographic findings,
but she continued to have myalgias, arthralgias, intermit-
tent trace hematuria and persistent elevation in acute
phase reactants and anti-PR3 levels. She also developed
episcleritis and epistaxis. A kidney biopsy showed mildly
active pauci-immune proliferative glomerulonephritis.
Based on the additional system involvement the diagnosis
of WG was felt to be confirmed, so after 4 months of Itra-
conazole, she was started on prednisone (1 mg/kg/day)
and cyclophosphamide (2 mg/kg/day) with rapid
improvement in her symptoms and normalization of
acute phase reactants. The anti-PR3 levels also became
negative.
Discussion
Blastomycosis is a rare but potentially fatal infection by
the fungus Blastomycosis dermatitidis. Blastomycosis is
endemic in the united states around Mississippi and Ohio
River basins, and Midwestern states, Canadian provinces
bordering the great lakes and small areas bordering the St.
Lawrence River, and Manitoba. Hyperendemicity in the
region surrounding Kenora, Ontario have recently been
reported with an annual incidence rate of 117.2 per
100,000 population [3]. Children account for 2–11% of
cases [4,5].
The initial clinical presentation of blastomycosis includes
fever, malaise, weight loss, cough and pleuritic chest pain.
Cutanous lesions and less commonly bone, genitourinary
and central nervous system involvement can occur. Most
cases of acute blastomycosis are self-limited [6], but the
mortality rate of untreated chronic blastomycosis
approaches 60% [7]. The diagnosis is made by demonstra-
tion of the organism in the lesions. Most experts advocate
specific targeted antifungal therapy for all cases of blasto-
mycosis. Itraconazole is the drug of choice for patients
with blastomycosis that is not life threatening, and does
not involve the central nervous system. Amphotericin B is
reserved for those with severe life threatening disease, cen-
tral nervous system involvement and immunocompro-
mised patients.
WG is a rare multisystem disorder, characterized by necro-
tizing granulomatous inflammation and pauci-immune
small vessel vasculitis [8]. The triad of paranasal sinus
involvement, pulmonary infiltration and renal involve-
ment is characteristic. Up to 90% of children with WG
have initial upper airway symptoms [9], such as nasal dis-
charge, sinusitis, or epistaxis. Lower respiratory symptoms
occur in 74% of children with WG [9], symptoms include
cough, dyspnea, and hemoptysis. Nodular and cavitating
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lung lesion are often visible on radiographs. Renal disease
occurs in 61% of children with WG [9] and often leads to
renal failure. Disease of the skin (purpura, vesicles,
papules, and nodules);CNS (cranial nerve palsy, seizures
and peripheral neuropathy); heart (myocardial infarction,
arrhythmia, and valvulitis); and eyes (scleritis, episcleritis,
dacrocystitis, and corneal ulcers) may occur.
The diagnosis of WG can be difficult; tissue diagnosis of
necrotizing granulomatous inflammation is the gold
standard. The diagnosis is supported by the presence of C-
ANCA (anti-PR3). Although C-ANCA has a high specifi-
city 90–95% [10,11], it has been reported in patients with
infections such as HIV, CMV Mycobacterium avium-inter-
cellulare, invasive amebiasis, Bartonella Henessae, and
Malaria. [12-18]. A positive C-ANCA can also occur in
connective tissue diseases such as systemic lupus ery-
thematosus and rheumatoid arthritis [19], as well as other
vasculitides including microscopic polyangitis and Churg-
Strauss syndrome [20]. Accordingly, many authorities feel
that neither the presence of a positive C-ANCA nor posi-
tive PR3 antibodies should be used to replace a tissue
biopsy in confirming the diagnosis of WG.
In our patient, the clinical picture of malaise, weight loss,
myalgia, arthralgia, cavitating and nodular lung lesions,
microscopic hematuria, episcleritis, nasal crusting and
epistaxis supported by the finding of a positive C-ANCA
suggested the diagnosis of WG. Open lung biopsy con-
firmed the diagnosis of blastomycosis and the histology
was strongly suggestive of a co-existing granulomatous
vasculitis. Although granulomatous changes in tissues can
certainly occur with blastomycosis the extent of the vascu-
lar changes were felt to be more than could be explained
by blastomycosis alone.
Although, there has been other reports of ANCA associ-
ated vasculitis triggered by fungal infection [21,22], as far
as we can ascertain this is the first report of WG co-existing
with tissue proven blastomycosis infection. The temporal
correlation of the symptoms suggests that the fungal infec-
tion may have triggered the systemic vasculitis. The other
possible explanation could be given the very high inci-
dence of blastomycosis in Kenora region in Ontario, a
patient with evolving WG could contract blastomycosis.
The unusual association of blastomycosis and WG raises
the intriguing possibility that infections, particularly
those in which granulomata formation occurs, may be
one of the triggers for WG in the predisposed host [23].
Epidemiological evidence to support this hypothesis is
presently lacking. There has been anecdotal (albeit
unpublished) evidence that there was a recent increase in
the occurrence of WG in children in several areas of North
America, suggesting perhaps that infection can be a trigger
for WG in children. The recent development of a pediatric
Wegener's registry by the Childhood Arthritis and Rheu-
matology Research Alliance (CARRA) will hopefully allow
the accrual of epidemiologic evidence that will help con-
firm or refute this possibility.
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